Do you want to read an article? Please log in or register.
Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort
Further Publications Anesthesiology
Related content
Viral Infections, Non-HIV
Effect of Hepatitis B virus on Steatosis in Hepatitis C virus co-infected subjects: a multi-center study and systematic review
J Viral Hepat.
Goossens N, de Vito C, Mangia A, Clément S, Cenderello G, Barrera F, D'Ambrosio R, Coppola N, Zampino R, Stanzione M, Adinolfi LE, Wedemeyer H, Semmo N, Müllhaupt B, Semela D, Malinverni R, Moradpour D, Heim M, Trincucci G, Rubbia-Brandt , Negro F
doi: 10.1111/jvh.12891.
Viral Infections, Non-HIV
Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international study
Clin Infect Dis.
Artenie AA, Cunningham EB, Dore GJ, Conway B, Dalgard O, Powis J, Bruggmann P, Hellard M, Cooper C, Read P, Feld JJ, Hajarizadeh B, Amin J, Lacombe K, Stedman C, Litwin AH, Marks P, Matthews GV, Quiene S, Erratt A, Bruneau J, Grebely J
doi: 10.1093/cid/ciz633.
Viral Infections, Non-HIV
Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030
Swiss Med Wkly.
Bruggmann P, Blach S, Deltenre P, Fehr J, Kouyos R, Lavanchy D, Müllhaupt B, Rauch A, Razavi H, Schmid P, Semela D, Stoeckle M, Negro F
doi: 10.4414/smw.2017.14543.
HIV / AIDS
A treatment as prevention trial to eliminate hepatitis C among men who have sex with men living with HIV in the Swiss HIV Cohort Study
Clin Infect Dis.
Braun DL, Hampel B, Ledergerber B, Grube C, Nguyen H, Künzler-Heule P, Shah C, Salazar-Vizcaya L, Conen A, Flepp M, Stöckle M, Béguelin C, Schmid P, Rougemont M, Delaloye J, Bernasconi E, Nicca D, Böni J, Rauch A, Kouyos RD, Günthard HF, Fehr JS
doi: 10.1093/cid/ciaa1124.
Viral Infections, Non-HIV
Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions
Swiss Med Wkly.
Rusch U, Robbins S, Razavi H, Vernazza P, Blach S, Bruggmann P, Müllhaupt B, Negro F, Semela D
doi: smw.2019.14694.
HIV / AIDS
Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons
AIDS.
Mocroft A, Ryom L, Oprea C, Li Q, Rauch A, Boesecke C, Uzdaviniene V, Sedlacek D, Llibre JM, Lacombe K, Nielsen LN, Florence E, Aho I, Chkhartishvili N, Szlavik J, Dragovic G, Leen C, Sambatakou H, Staub T, Laguno M, Elinav H, Tomažič J, Peters L, EuroSIDA study group.
doi: 10.1097/QAD.0000000000002570.
Viral Infections, Non-HIV
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
Open Forum Infect Dis
Roelens M, Bertisch B, Moradpour D, Cerny A, Semmo N, Schmid P, Müllhaupt B, Clerc O, Semela D, Junker C, Negro F, Keiser O, Swiss Hepatitis C Cohort Study .
doi: 10.1093/ofid/ofaa308
Viral Infections, Non-HIV
Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
Swiss Med Wkly.
Bachofner J, Valli PV, Bergamin I, Kröger A, Künzler P, Baserga A, Braun DL, Seifert B, Moncsek A, Fehr J, Semela D, Magenta L, Müllhaupt B, Terziroli Beretta-Piccoli B, Mertens J, The Swiss Hepatitis C Cohort Study.
doi: 10.4414/smw.2018.14560.
RECOMMENDED
Viral Infections, Non-HIV
Elimination of hepatitis C in Europe: can WHO targets be achieved?
★ 2
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Clin Microbiol Infect.
Maticic M, Lombardi A, Mondelli MU, Colombo M, ESCMID Study Group for Viral Hepatitis (ESGVH)
doi: 10.1016/j.cmi.2020.01.014.